迈博药业-B2025中期报告

4 5 12 38 47 49 52 55 72 76 Walkers Corporate Limited190 Elgin AvenueGeorge TownGrand Cayman KY1-9008Cayman Islands G79225300 8318A 183171712–1716 97927 Walkers Corporate Limited190 Elgin AvenueGeorge TownGrand Cayman KY1-9008Cayman Islands 50037 1 123 2181 www.mabpharm.cn 2.7152.7%913 CMAB009®CMAB009®EGFRS20240025FOLFIRIRAS/BRAFmCRCCMAB009®PCTPCTPCT/CN2016/070024CHO 50EGFR2%EGFRCMAB009®CMAB009® CMAB009®CSCO600CMAB009®10CMAB009® CMAB009®CMAB009®CMAB009®CMAB009®mCRCEGFRCMAB009®CMAB009® ✔CMAB007®S2023003075mgS20230031150mgIgECMAB007®H112CMAB007®IIIIgECMAB007®CMAB007® CMAB007®CMAB007®CMAB007®GPOCMAB007®4.8%CMAB007®CMAB007®CMAB007® ✓CMAB008®S202100251234656CMAB008® CMAB008®1,000688136CMAB008®CMAB008®CMAB008®31.8%MIS-CCMAB008® CMAB008®CMAB008®GMPPIC/SGMPCMAB008® CMAB015CMAB015IIIICMAB807/CMAB807XIIICMAB017IEGFRCMAB017CMAB022 203863 7,500GMPGMPGMP40,000CDMOCDMO PIC/SGMP ®CMAB009 CMAB009®EGFRFOLFIRImCRCCMAB009PCTPCTPCT/CN2016/070024CHO CMAB009® CMAB009®FOLFIRImCRCCMAB009®mCRCEGFRCMAB009®CMAB009® 50EGFR2%EGFRCMAB009®CMAB009®CMAB009®CSCO600CMAB009®10CMAB009®CMAB009® ®CMAB007 CMAB007®IgEIgECMAB007®IgEIgEIgECMAB007®4824CMAB007®CMAB007®CMAB007® CMAB007®S2023003075mgS20230031150mgIgECMAB007®H112CXSL230037775mgCXSL2300378150mgCMAB007®NDA CMAB007®CMAB007®CMAB007®CMAB007®CMAB007®GPOCMAB007®4.8%ABCMAB007®CMAB007®CMAB007® ®CMAB008 CMAB008®TNFS20210025 (i)(ii)(iii)(iv)6(v)(vi) CMAB008®CMAB008®CHOTNFTNFCMAB008®TNFTNFCMAB008®CMAB008® CMAB008®CMAB008®1,000IBD CMAB008® CMAB008®CMAB008®31.8%MIS-CCMAB008®GMPPIC/SGMPCMAB008® CMAB807/CMAB807XRANKLBG2IgG2RANKLCMAB807/CMAB807XRANKLRANKRANKLRANK RANKLRANKLRANKRANKCMAB807/CMAB807XRANKLRANK CMAB807/CMAB807XIIINDACMAB807/CMAB807XNDACMAB807/CMAB807XCMAB807/CMAB807X CMAB017EGFRCMAB017G1IgG1FcCMAB017CMAB017CMAB017CMAB017CMAB01724–72I CMAB015secukinumabIgG117AIL-17A17IL-17IL-17ACMAB015IL-17ACMAB015IIIICMAB015NDA CMAB819CMAB819ICMAB819CMAB819 CMAB022®stelara®ustekinumab12IL-1223IL-23IL-12IL-23P40IL-12R1IL-12IL-23FDAUNITI-1UNITI-2IM-UNITITNFCMAB022 CMAB023TSLPIgG2-lambdaTEZSPIRE (Tezepelumab)TSLPTSLPTSLPCMAB023 CMAB016®Dupixent®dupilumabG4IgG4CMAB0164IL-4IL-413IL-13FDACOPDBOREASNOTUS52COPD30%34%52CMAB016 CMAB008CMAB007CMAB009CMAB807/CMAB807XNDAGMP G7930,000(i)3×1,500(ii)400(iii)100CMAB008CMAB007CMAB009GMPPIC/SGMP 100,746(i)7,50018,000(ii)1,000(iii)7,500GMPGMPGMP40,000 CDMOCDMOCMAB008®GMPPIC/SCMAB008GMPCMAB008 (i)(ii) GMPGMP PIC/S CMAB008CMAB007CMAB009CMAB807/CMAB807XCMAB015 108.5152.7%274.2 14.1133.2%32.9 94.4155.7%241.288% 1.3357.3%6.0 0.55.6%0.6 56.357.7%23.8 60.715.3%51.4 5.40.1%5.4 97.6103.0%2.9 94.553.8%145.3111.031.3%145.8 48.6256.4 59.3 288100,74633.250,835156.880.018194.3100.1 412,4084,124,080,000 90.7%9.3%91.2%8.8% 100%90.7%91.2% (1)(2) 1.21.10.80.7 1,144.5 38344339 (1)27 280195 XV(i)XV78(ii)352(iii)C3 (1)4,124,080,000(2) XVXV78352 336 (1)Asia Mabtech49.95%4.05%Asia Mabtech100%Asia MabtechAsia Pacific Immunotech VentureAsia Pacific Immunotech VentureXV167,025,000Asia Mabtech2,059,975,000 (2)CDH PE18.00%CDH PECDH FundCDH FundCDH PECDH FundCDH VCDH VChina Diamond V80%ChinaDiamond VChina Diamond100% FH InvestmentLink Best Capital LimitedLink Best Capital Limited 336 6283,512,50083,512,500333372,670,8761.76% 20% 1.50 72,670,8764,124,080,0001.76% (i)(ii)1%17(iii)0.1%(iv) 13.51B(1) 2410 13.1313.19 Ernst & Young27/F, One Taikoo Place979 King’s RoadQuarry Bay, Hong Kong 4971邁 博 药 業343434 2410 34 1. 邁 博 药 業 有 限 公 司190 Elgin Avenue, George Town, Grand Cayman KY1-9008,Cayman IslandsG79 Asia Mabtech Limited 2. 34 3. 21 21 4. 8 10% 5. 6. 7. 8. 9. 10. 11. 12. 13. 8,145,0008,040,0002,142,0002,117,000 14. a.100,746 15. 15. 60 a.100,74633,161,00033,547,00050,835156,766,000168,903,000b.194,271,000195,164,000 19. 20. 21. (a) 21. (a) a. b.45,000,0003.7%22,500,000847,0004,000,000380,00018,500,0001,801,000 (b) 21. (b) 60 a.CMAB80766,038,00047,170,000 21. (c) 22. TNFTNFcachexinCD4+ DNA